The title compound, C13H15ClN2O2S, assumes a shallow boat conformation where the methyl and 4-chlorothiophenyl substituents in the alpha-positions are situated trans to one another, and the latter is folded across the piperazinedione ring.
COMPOSITIONS AND METHODS FOR INHIBITING ACTIVITY OF HYPOXIA-INDUCIBLE TRANSCRIPTION FACTOR COMPLEX AND ITS USE FOR TREATMENT OF TUMORS